Conference Call and Webcast to Be Held Tuesday, April 2, 2019 at 8:00 am ET / 1:00 pm BST UCLB spinout, Autolus Therapeutics, a clinical-stage biopharmaceutical [...]
UCLB, the wholly owned subsidiary technology commercialisation company of UCL, has appointed Dr Anne Lane as its new Managing Director. As part of UCL Innovatio [...]
London, UK, December 17th, 2018. LifeArc, a leading UK medical research charity, is delighted to launch a new Technology Transfer Fellowship programme in partn [...]
Medical software developed at UCL that overlays tumour information from MRI scans onto ultrasound images can help guide surgeons conducting biopsies and improve [...]
The government has published the second Life Sciences Sector Deal, which outlines public and private sector investments into the sector. Investments into three [...]
A single infusion of FLT180a resulted in sustained mean Factor IX activity of 45%, with no toxicity or adverse effects, and eliminated need for patient infusion [...]
UCLTF has invested in a series A round for immuno-oncology company IGEM Therapeutics. The £5million funding round also included investment from Alsa Holdings an [...]
Engitix Ltd, a company pioneering the development of both tissue-specific and disease-specific human extracellular matrix (ECM) for accelerating and improving t [...]
SmartTarget Ltd, a spinout of UCL (University College London) that has developed a CE-approved device for precision prostate biopsy and focal therapy, is please [...]
UCL spinout Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies, [...]
